These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33211810)

  • 21. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Spencer EA; Klang E; Dolinger M; Pittman N; Dubinsky MC
    Inflamm Bowel Dis; 2021 Oct; 27(11):1862-1864. PubMed ID: 34427638
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?
    Hassani D; Amiri MM; Maghsood F; Salimi V; Kardar GA; Barati O; Hashemian SMR; Jeddi-Tehrani M; Zarnani AH; Shokri F
    Iran J Immunol; 2021 Mar; 18(1):47-53. PubMed ID: 33787513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs.
    Martínez-Domínguez SJ; García-Mateo S; Sainz-Arnal P; Martínez-García J; Gallego-Llera B; Lozano-Limones MJ; Hidalgo S; Gargallo-Puyuelo CJ; Latre-Santos M; Nocito-Colon MML; Martínez-Lostao L; Refaie E; Arroyo-Villarino MT; Del Rio-Nechaevsky M; Ramirez-Labrada A; Pardo J; Gomollón F; Baptista PM
    Sci Rep; 2023 Dec; 13(1):23061. PubMed ID: 38155275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing for COVID-19: a few points to remember.
    Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
    Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study.
    Rauber C; Tiwari-Heckler S; Pfeiffenberger J; Mehrabi A; Lund F; Gath P; Mieth M; Merle U; Rupp C
    Transplant Proc; 2021 May; 53(4):1112-1117. PubMed ID: 33451759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.
    Fong D; San Nicolò KO; Alber M; Mitterer M
    Wien Klin Wochenschr; 2021 Apr; 133(7-8):359-363. PubMed ID: 33502609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?
    Malickova K; Kratka Z; Luxova S; Bortlik M; Lukas M
    Scand J Gastroenterol; 2020 Aug; 55(8):917-919. PubMed ID: 32663041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of COVID-19 Virus Infection in Semnan province.
    Jandaghi E; Hemati M; Mohammadlou M; Jandaghi J; Mirmohammadkhani M; Danaei N; Kokhaei P
    Iran J Immunol; 2021 Mar; 18(1):74-81. PubMed ID: 33787516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study.
    Desai A; Soni A; Hayney MS; Hashash JG; Kochhar GS; Farraye FA; Caldera F
    Inflamm Bowel Dis; 2024 Jul; 30(7):1094-1102. PubMed ID: 37540900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
    J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological response to vaccination against coronavirus disease-19 in patients with inflammatory bowel disease.
    Mathur A; Sahu S; Rai S; Ghoshal U; Ghoshal UC
    Indian J Gastroenterol; 2023 Feb; 42(1):64-69. PubMed ID: 36598745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of SARS-Coronavirus-2 in patients with inflammatory bowel disease and the role of soluble angiotensin converting Enzyme2.
    Shahrokh S; Baradaran Ghavami S; Asadzadeh Aghdaei H; Parigi TL; Farmani M; Danese S; Ebrahimi Daryani N; Vossoughinia H; Balaii H; Alborzi F; Khoramjoo SM; Khanabadi B; Seyed Salehi A; Bastani A; Sharifi M; Safari MT; Malekpour H; Sherkat G; Saberafsharian M; Miri MB; Moosavi SH; Anaraki F; Nazemalhosseini-Mojarad E; Mohebbi SR; Shojaie S; Pourhoseingholi MA; Zali MR
    Arch Physiol Biochem; 2024 Jun; 130(3):325-332. PubMed ID: 35617972
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Guerra I; Algaba A; Jiménez L; Mar Aller M; Garza D; Bonillo D; Molina Esteban LM; Bermejo F
    Inflamm Bowel Dis; 2021 Jan; 27(1):25-33. PubMed ID: 32830267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
    Kennedy NA; Goodhand JR; Bewshea C; Nice R; Chee D; Lin S; Chanchlani N; Butterworth J; Cooney R; Croft NM; Hart AL; Irving PM; Kok KB; Lamb CA; Limdi JK; Macdonald J; McGovern DP; Mehta SJ; Murray CD; Patel KV; Pollok RC; Raine T; Russell RK; Selinger CP; Smith PJ; Bowden J; McDonald TJ; Lees CW; Sebastian S; Powell N; Ahmad T;
    Gut; 2021 May; 70(5):865-875. PubMed ID: 33753421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.